Rigorous Statistical Approach to Understanding cancer Cachexia and therapeutic Response
As researchers investigating the complex interplay between cancer, cachexia (muscle wasting), and treatment efficacy, we employed a extensive and robust statistical framework to ensure the validity and reliability of our findings. This document details the key statistical methods utilized throughout our study, demonstrating our commitment to scientific rigor and openness. We understand you need confidence in the data, and we’ve taken every step to deliver that.
Data Analysis Overview
Our analyses spanned multiple data types – from animal studies and in vitro experiments to RNA sequencing, ChIP sequencing, proteomics, and clinical datasets. Each data type required specific statistical approaches, all designed to minimize bias and maximize the accuracy of our conclusions. Here’s a breakdown of the methods we used:
1. Baseline Comparisons & Group Differences
* ANOVA & ANCOVA: We used Analysis of Variance (ANOVA) to compare means across multiple groups. When pretreatment body weight differed between groups,we employed Analysis of Covariance (ANCOVA) to adjust for this variable,ensuring a fair comparison of treatment effects. This is crucial because pretreatment weight can significantly influence outcomes.
* Log-Rank test & Kaplan-Meier Survival Analysis: To assess survival differences between treatment groups, we utilized Kaplan-Meier survival analyses, evaluated using the log-rank test. This method allows us to visualize and statistically compare the time-to-event data, like survival or disease progression.
* Heteroskedasticity-Consistent Variance-Covariance Matrix: To account for potential non-constant variance in our data, we used a heteroskedasticity-consistent variance-covariance matrix. This provides more robust estimates, notably when dealing with complex biological datasets.
2. Exploring Relationships & Correlations
* Scatterplots: We visually examined the relationships between tissue mass measurements and pretreatment weights using scatterplots. This initial step helps identify potential trends and informs subsequent statistical modeling.
* Robust Statistical Modeling: All models were carefully adjusted for pretreatment body weight, a critical factor in cachexia studies.We prioritized robust statistical methods to minimize the impact of outliers and ensure the reliability of our results.
3. Omics Data Analysis - Unraveling Molecular Mechanisms
* RNA-seq (DESeq2): Differential gene expression analysis was performed using DESeq2, a widely respected tool for RNA sequencing data. Statistical significance was steadfast using a two-sided Wald test, providing a comprehensive view of gene expression changes.
* ChIP-seq (MACS2): We identified regions of the genome bound by specific proteins using ChIP-seq, employing MACS2 for peak calling. This helps us understand the regulatory mechanisms driving observed changes.
* Proteomics (Spectrum Mill): Proteomics data was normalized using Spectrum Mill, ensuring accurate quantification of protein levels. This complements the RNA-seq data, providing a holistic view of molecular changes.
* clinical Dataset Analysis (SAS v.9.4): Analyses of clinical data from the NKT2152 study were conducted using SAS (version 9.4),a standard in clinical data analysis.
4. Key Considerations & Transparency
* Sample Size (n): n* always represents biological replicates, not technical replicates. For *in vivo studies, n* refers to the number of individual animals. For *in vitro studies, it represents independent biological experiments.
* Blinding & Randomization: Mice were randomly assigned to treatment groups, and histological assessments were performed blind to treatment. While blinding wasn’t possible for all analyses, treatments were randomly allocated in in vitro studies.
* Replication: all experiments were replicated at least twice to ensure reproducibility.
* Significance Threshold: Statistical significance was set at a two-sided P* ≤ 0.05, with exact *P values reported whenever possible. A one-sided *P* value calculation was used specifically for Extended Data Fig. 7g-m.
* data Exclusion: Importantly, no data were excluded from our analyses.
* Sample Size Justification: While we didn’t perform a formal power analysis to predetermine sample sizes, our chosen sample sizes align with those used in established research on xenograft models and molecular analyses of kidney cancer and cachexia (Kir et al
Keep reading